Price Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$27K Buy
182
+78
+75% +$12.1K 0.01% 166
2020
Q2
$17K Buy
+104
New +$16K 0.01% 130
2020
Q1
Sell
-24
Closed -$3K 466
2019
Q4
$3K Buy
+24
New +$2.78K ﹤0.01% 218
2018
Q3
Sell
-313
Closed -$26K 317
2018
Q2
$26K Buy
313
+193
+161% +$15.9K 0.01% 175
2018
Q1
$9K Sell
120
-120
-50% -$9.66K 0.01% 171
2017
Q4
$20K Buy
+240
New +$20.4K 0.01% 117

Other funds holding LLY

Price Wealth's LLY Position: Q3 2020 in Review

Price Wealth increased its Eli Lilly (LLY) stake by 75% in Q3 2020, buying an estimated $12.1K and bringing the position to 182 shares worth $27K. The position accounts for 0.01% of the portfolio, ranked #166.

Price Wealth first reported a position in LLY in Q4 2017 and has held it in 6 quarters since. 1,773 funds tracked by Wall St. Rank hold LLY as of Q3 2020.

  • Price Wealth held 182 shares of Eli Lilly worth $27K as of Q3 2020.
  • Price Wealth bought 78 Eli Lilly shares in Q3 2020, an estimated $12.1K.
  • Eli Lilly made up 0.01% of Price Wealth's portfolio in Q3 2020, its #166 holding.
  • Price Wealth first reported a position in Eli Lilly in Q4 2017 and has held it in 6 quarters since.
  • 1,773 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2020.

Based on Price Wealth's 13F filing for Q3 2020, filed 22 Oct 2020.